Progression from <i>Candida auris</i> Colonization Screening to Clinical Case Status, United States, 2016–2023
During 2016-2023, among 21,195 US patients who tested positive for Candida auris colonization, 6.9% were subsequently found to have a positive clinical specimen (2.8% from blood). Strategies are needed to prevent invasive C. auris infections among patients with colonization (e.g., through patient decolonization).
Authors
- Anna Baker (ORCID: https://orcid.org/0000-0002-8874-8827)
- Kaitlin Forsberg (ORCID: https://orcid.org/0000-0002-5779-2446)
- Meghan Lyman (ORCID: https://orcid.org/0000-0001-7925-2232)
- Jeremy A.W. Gold (ORCID: https://orcid.org/0000-0002-5054-7616)
- Sophie Jones (ORCID: https://orcid.org/0000-0003-0350-2578)
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2025-07-24
- DOI
- https://doi.org/10.3201/eid3108.250315
- Citations
- 11
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 15.36